Mary Lynne Hedley, PhD

Senior Fellow and Strategic Advisor

The Broad Institute of M.I.T. and Harvard

Dr. Mary Lynne Hedley, PhD, is a Senior Fellow and Strategic Advisor at The Broad Institute of M.I.T. and Harvard and Co-Founder, former President, Director and Chief Operating Officer at TESARO, Inc.

Mary Lynne has extensive experience in the discovery and development of new medicines, formerly serving as Executive Vice President and Chief Scientific Officer at MGI PHARMA, Executive Vice President of Eisai Corporation of North America, Executive Vice President of Operations, and Chief Scientific Officer of Abraxis BioScience.

Mary Lynne also sits on the Veeva Systems (NASDAQ: VEEV) Board of Directors and is a member of the Helsinn Holdings’ Board of Directors.

Mary Lynne holds a PhD in Immunology from the University of Texas Southwestern Medical Center and a BS in Microbiology from Purdue University. In addition, she completed two consecutive postdoctoral fellowships at Harvard University.

Your browser is out-of-date!

Update your browser to view this website correctly. Outdated Browser